Perfil epidemiológico de doenças oculares assistidas em serviço especializado
Revista Brasileira de Oftalmologia · 20.05.2026 · 85
DOI: 10.37039/1982.8551.20260047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Brasileira de Oftalmologia, erschienen am 20.05.2026. Verfasst von Amanda Xavier Miranda da Silva und 2 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objective
To describe the epidemiological profile of ocular diseases in patients treated in an outpatient service.
Methods
This is a descriptive, cross-sectional, and retrospective study conducted based on 402 medical records.
Results
A higher frequency of female patients was observed (54.7%), with an average age of 51.7 years. Most patients were retired (33.8%). Hypertension was the most common comorbidity (34.3%), increasing the probability of developing ocular diseases by 2.5 times. The most common diagnoses were ametropias (30.3%), cataract (17%), and dry eye syndrome (11.6%). The ocular disease is 44% less likely to develop in women, and individuals with comorbidities are 1.77 times to do so.
Conclusion
The study highlights the importance of comprehensive care, with an emphasis on preventive measures, especially when other comorbidities are present.
Zitieren
APA
Silva, A. X. M. D., Silva, L. I. D., & Sousa, M. N. A. D. (2026). Perfil epidemiológico de doenças oculares assistidas em serviço especializado. Revista Brasileira de Oftalmologia, 85. https://doi.org/10.37039/1982.8551.20260047
Vancouver
Silva AXMD, Silva LID, Sousa MNAD. Perfil epidemiológico de doenças oculares assistidas em serviço especializado. Revista Brasileira de Oftalmologia. 2026;85. doi:10.37039/1982.8551.20260047
BibTeX
@article{Silva2026,
author = {Silva, Amanda Xavier Miranda da and Silva, Luana Idalino da and Sousa, Milena Nunes Alves de},
title = {Perfil epidemiológico de doenças oculares assistidas em serviço especializado},
journal = {Revista Brasileira de Oftalmologia},
year = {2026},
volume = {85},
doi = {10.37039/1982.8551.20260047}
}
EUVIMED